Coverage
-
August 16, 2023
Otsuka Holdings Co. Ltd.'s Taiho unit nabbed a win Tuesday when a Delaware federal judge upheld its patent for the metastatic colorectal cancer drug treatment Lonsurf, likely keeping a generic version of the drug off the U.S. market for years to come.
1 other articles on this case.
View all »